CAS: 52080-57-6; (6S,8S,9S,10R,13S,14S,17R)-6-Chloro-17-Hydroxy-17-(2-Hydroxyacetyl)-10,13-Dimethyl-6,7,8,9,12,14,15,16-Octahydrocyclopenta[a]Phenanthrene-3,11-Dione

该化合物是一种合成的可口可乐体,具有抗炎和免疫抑制特性,是甲状腺素的衍生物,其特点是六位位置存在氯原子,这增加了其效力和效力.氯甲状腺素通常用于治疗各种炎症和自免疫性疾病,如过敏,哮喘和某些皮肤病.通过调节免疫反应和抑制炎症调节器释放而形成的复合功能.其药理效应归因于其与凝胶类受体结合的能力,导致基因表达方式的改变.氯甲状腺素以各种形式施用,包括口服药片和注射溶液,其剂量根据所治疗的特定条件而定制.与其他可口可乐类固醇一样,潜在的副作用可能包括体重增加,血糖含量增加和感染敏感程度,在治疗期间需要谨慎监测.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-12391691-B2
      优先权日:2018-11-16
      标题:Synthesis of key intermediate of KRAS G12C inhibitor compound
      发明人:PARSONS ANDREW THOMAS; COCHRAN BRIAN MCNEIL; POWAZINIK IV WILLIAM; CAPORINI MARC ANTHONY
      权利人:AMGEN INC
      摘要:The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure n nuseful for the synthesis of compounds that target KRAS G12C mutations, such as

      专利号:US-2025206736-A1
      优先权日:2019-11-14
      标题 :Synthesis of kras g12c inhibitor compound
      发明人:CORBETT MICHAEL THOMAS; CAILLE SEBASTIEN
      权利人:AMGEN INC
      摘要:The present disclosure relates to an improved, efficient, scalable process to prepare intermediate compounds, such as 2-isopropyl-4-methylpyridin-3-amine, useful for the synthesis of compounds, such as Compound 9, for the treatment of KRAS G12C mutated cancers.

      专利号:WO-2022226312-A1
      优先权日:2021-04-22
      标 题:Combination nucleotide pool depletion for treatment of viral infections and cancers
      发明人:KUMAR VIKRAM; HESSON DAVID; DEMAREST JAMES
      权利人:CLEAR CREEK BIO INC
      摘要:The invention provides methods of treating cancers and viral infections by providing a combination of agents that inhibit both nucleotide synthesis and nucleotide salvage in the cells of a subject to prevent cancer proliferation and viral replication. The invention provides methods of depleting nucleotide pools by using both inhibitors of dihydroorotate dehydrogenase (DHODH), such as brequinar, which block synthesis of pyrimidine-based nucleotides, in combination of one or more nucleotide salvage inhibitors, for example deoxycytidine kinase (dCK) inhibitors, Equilibrative nucleoside transporter (ENT) inhibitors, and Uridine-cytidine kinase (UCK) inhibitors, which inhibit salvage of purine and/or pyrimidine-based nucleotides or nucleosides

      专利号:US-2024287041-A1
      优先权日:2021-05-20
      标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
      发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
      权利人:KARYOPHARM THERAPEUTICS INC
      摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

      专利号:US-11850220-B2
      优先权日:2020-05-19
      标题 :Synthesis of ibuprofen hybrid conjugates as anti-inflammatory and analgesic agents
      发明人:PANDA SIVA
      权利人:UNIV RES INST INC AUGUSTA
      摘要:Disclosed herein as ibuprofen hybrid conjugates and methods of their use to reduce inflammation, pain, and fever. The ibuprofen conjugates have potent anti-inflammatory and analgesic properties with low potential for ulcerogenic activity. An exemplary compound is an ibuprofen-amino acid-4-aminophenol hybrid. Also disclosed are methods of treating or reducing inflammation, pain, and fever in a subject.

      专利号:US-6150403-A
      优先权日:1997-10-14
      标 题 :Topical compositions for regulating the oily/shiny appearance of skin
      发明人:BIEDERMANN KIMBERLY A; SCHUBERT HARRY L; PARRAN JR JOHN J
      权利人:PROCTER & GAMBLE
      摘要:The present invention relates to methods for inhibiting sebaceous gland activity in mammalian skin comprising administration of a topical composition comprising dehydroacetic acid or pharmaceutically acceptable salts thereof, and a dermatologically-acceptable carrier. The present invention also relates to methods and topical compositions further comprising agents which regulate the oily and/or shiny appearance of skin, and agents which treat acne and related skin disorders in mammalian skin and scalp. Methods of reducing sebum synthesis with the use of dehydroacetic acid, methods of regulating the oily and/or shiny appearance of skin, and methods of treating acne and other skin disorders are also encompassed by the present invention.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: SCHWARZ K, KONZELMANN M, WRAN R. [On the local effects of 6alpha- chloroprednisone acetate]. Praxis. 1961 Sep 28;50:1015-8. German.

      合成参考文献


      参考文献:10.1007/bf00588839
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知